TRAX position history
The shares of First Tracks Biotherapeutics (TRAX) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 603,489 shares, $12M, 1.7% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|